Watson Pharmaceuticals Wire
Comprehensive News Feed for Watson Pharmaceuticals.
Results 1 - 20 of 130 in Watson Pharmaceuticals
-
Strong tailwinds could set generic drug makers flying
... be of interest to investors are: Teva Pharmaceutical Industries Ltd. TEVA-Q , Mylan Inc. MYL-Q , and Watson Pharmaceuticals Inc. WPI-N . Teva Pharmaceutical, the dominant player in the global industry, seems best positioned to ride the tailwinds ... Comment?
-
Watson announces new program designed for advanced prostate cancer patients
... bone health among men with advanced prostate cancer taking long-term androgen-deprivation therapy. Watson Pharmaceuticals announced Monday that it would supply educational brochures and free 30-day supplies of calcium and vitamin D supplements to ... Comment?
-
How to Play Generic Drug Stocks
... and faces some of the biggest risks posed by US health-care reform, the generic drugmakers like Teva, Watson Pharmaceuticals ( WPI ), and Mylan ( MYL ) stand to benefit greatly. According to IMS Health, a health care information and consulting ... Comment?
-
New Published Data Demonstrate Long-Term Safety, Efficacy and...
Watson Pharmaceuticals, Inc. today announced that the results of an open-label extension of two Phase 3 studies, published in the December issue of the peer-reviewed journal Urology, demonstrate long-term safety and tolerability of RAPAFLO for up to 52 weeks of treatment. Comment?
-
Biotech Stocks: Drug stocks climb; Lilly falls on forecast
... its blockbuster psychiatric drug Zyprexa. Lilly also expects its tax rate to climb to 25%. Shares of Watson Pharmaceuticals /quotes/comstock/13*!wpi /quotes/nls/wpi ( WPI 38.30 , +0.65 , +1.73% ) rose 2% to $38.22. Analysts at SunTrust Robinson ... Comment?
-
New Published Data Demonstrate Long-Term Safety, Efficacy And...
New Published Data Demonstrate Long-Term Safety, Efficacy And Tolerability Of Watson's RAPAFLO For Benign Prostatic Hyperplasia Main Category: Prostate / Prostate Cancer Also Included In: Urology / Nephrology ; Clinical Trials / Drug Trials ; Pharma Industry / Biotech Industry Article Date: 10 Dec 2009 - 3:00 PST Watson Pharmaceuticals, Inc. Comment?
-
News and FDA Updates for Unigene Laboratories
... and to better match resources with market demand and the Companys strategic objectives. On 12/09/09, Watson Pharmaceuticals, Inc. (NYSE:WPI) announced the results of an open-label extension of two Phase 3 studies, published in the December issue of ... Comment?
-
Watson Pharmaceuticals' RAPAFLO demonstrates safety and tolerability in BPH treatment
Watson Pharmaceuticals, Inc. today announced that the results of an open-label extension of two Phase 3 studies, published in the December issue of the peer-reviewed journal Urology , demonstrate long-term safety and tolerability of RAPAFLO A for up to 52 weeks of treatment. Comment?
-
Watson Completes Acquisition Of Arrow Group
Watson Pharmaceuticals, Inc. today announced that it has completed the acquisition of Arrow Group for a combination of cash and stock. Comment?
-
Teva Seen Among Leaders For Ratiopharm
... especially in Germany, where its presence is thin. "Bloomberg" added that Mylan Inc. (NYSE: MYL), Watson Pharmaceuticals Inc. (NYSE: WPI) and Pfizer Inc. (NYSE: PFE; LSE: PFZ) are interested in part of Ratiopharm. Ratiopharm had 1.7 billion in sales ... Comment?
-
News and FDA Updates for Watson
... of all headlines and biomedical stock developments can be found on BioMedReports.Com On 12/04/09, Watson Pharmaceuticals, Inc. (NYSE:WPI), a leading global specialty pharmaceutical company, confirmed that its subsidiary, Watson Laboratories, ... Comment?
-
Watson seeks FDA approval for generic insomnia treatment
MORRISTOWN,A N.J. Generic drug maker Watson Pharmaceuticals has filed for regulatory approval with the Food and Drug Administration for a version of an insomnia drug, prompting a lawsuit from the branded druga s manufacturer. Comment?
-
Watson challenges Takeda's Rozerem patent
Watson Pharmaceuticals Inc. said Friday it is challenging Takeda Pharmaceutical Co.'s patent on the insomnia treatment Rozerem. Comment?
-
Watson seeks FDA approval to market generic Rozerem
4 December 2009 - US specialty pharmaceutical company Watson Pharmaceuticals Inc (NYSE: WPI) said today that its subsidiary, Watson Laboratories Inc-Florida, filed an Abbreviated New Drug Application (ANDA) with the US Food and Drug Administration ... Comment?
-
Watson challenges Takeda's Rozerem patent
Watson Pharmaceuticals Inc. said Friday it is challenging Takeda Pharmaceutical Co.'s patent on the insomnia treatment Rozerem. Comment?
-
Watson Files FDA Application for Generic Rozerem(R) - Paragraph IV Litigation Underway
Watson Pharmaceuticals, today confirmed that its subsidiary, Watson Laboratories, Inc.-Florida, filed an Abbreviated New Drug Application with the U.S. Food and Drug Administration seeking approval to market its 8mg ramelteon tablets prior to the expiration of a patent owned by Takeda Pharmaceutical Company Limited. Comment?
-
Impax Labs acquires two generic drugs
HAYWARD,A Calif. Generic drug maker Impax Labs has bought the rights to two generic drugs from Watson Pharmaceuticals and Arrow Group, which Watson recently acquired. Comment?
-
... spokesman Markus Braun declined to comment as did officials at Commerzbank and RBS. Mylan Inc. and Watson Pharmaceuticals Inc. of the U.S. are interested in buying parts of the company, two of the people said. Pfizer Inc. is also interested, they ... Comment?
-
Watson Pharmaceuticals acquires Arrow Group
MORRIS TWP. - Watson Pharmaceuticals Inc. announced late on Wednesday that it has completed its acquisition of Arrow Group for a combination of cash and stock. Comment?
-
Teva, Sanofi, Sinopharm Said to Be Frontrunners for Merckle's Ratiopharm
w/Photo
... spokesman Markus Braun declined to comment as did officials at Commerzbank and RBS. Mylan Inc. and Watson Pharmaceuticals Inc. of the U.S. are interested in buying parts of the company, two of the people said. Pfizer Inc. is also interested, they ... Comment?
Watson Pharmaceuticals Forum
Most Popular
- A bleak future for black children and youth - 303 comments
- PolitiFact's Lie of the Year: 'Death panels' - 343 comments
- Shame On Me For Voting For Obama - 213 comments
- TV talent show exposes China's race issue - 106 comments
- Angels can't fly, scientist says - 74 comments
- Man fatally shot in Berwyn - 92 comments
- McCain: Try sanctions first against Iran - 62 comments
- 911? My son won't stop playing video games - 49 comments
- Indian trucks not allowed to pass through Pakistan - 212 comments
- Police search for supermarket butt sniffer - 29 comments
|
Reach local customers. Engage a specific demographic. Maximize business-to-business opportunities. Topix can deliver your message.
|
Copyright ©2009 Topix LLC
